艾昆纬-驯服复杂的临床试验生态系统-一种已经产生影响的新方法（英）

White PaperTaming the Complex Clinical-Trial Ecosystem A new approach that’s already making an impact.IQVIA TECHNOLOGIES2 | Taming the Complex Clinical-Trial EcosystemAs the clinical trial ecosystem expands to include a wide range of new and innovative technology solutions, clinical trial sites that, ideally, stand to benefit from these offerings, are becoming increasingly vocal about the corresponding administrative complexity. With every new system, a site team must navigate additional logins, portals, and interfaces. To tame this complex clinical-trial ecosystem, IQVIA Technologies developed One Home for Sites™ (One Home), a vendor- and sponsor-agnostic solution to tech overload that enables single sign-on (SSO) and study organization across clinical systems. In a widely attended webinar, IQVIA’s Lesley Freese, Senior Product Manager for One Home; Rob Osterhaus, Director of Partner Ecosystem; and Julie Lightfoot, Senior Director of Alliance Management, spoke with Brian Hunter, VP at CNS Healthcare, and Kasey Bumber, Senior Director of Product Management at Signant Health, to share perspectives on the progress and promise of One Home. Together, these clinical stakeholders considered how One Home can help chart a mutually beneficial path toward streamlined clinical trial management for sponsors, sites, and technology providers.The multiplication effectCNS Healthcare’s network of experienced sites is no stranger to the increasing technological load on the clinical landscape. According to Hunter, “It’s not uncommon for there to be 12 to 15 vendors per study for our sites. When you multiply that by the number of studies going on simultaneously at each of our sites, that is a huge number of portals that we’re logging into regularly to complete our required tasks.” Figure 1 represents this multiplication effect.Though the industry is striving for better collaboration, sites are still navigating work across multiple sponsors, CROs, and vendors. Site coordinators now serve as intermediaries between trial participants and technology providers, frequently stepping in to help patients navigate their own set of patient portals and apps. Burnout and turnover often result.As a leader in the industry, IQVIA recognized the need for a solution to tech overload and sought to design a system that provided a single point of entry for its own array of technology platforms and portals. Per Freese, “When I started interviewing site staff on how best to approach this, many very kindly said, I’m glad to see you’re doing this, but at the end of day, it doesn’t solve my problem because I have lots of additional systems from other technology vendors that I need to access.” Figure 1: How technology solutions overburden trial sites“It’s not uncommon for there to be 12 to 15 vendors per study for our sites.”— Brian Hunter, CNS Healthcareiqvia.com/onehome | 3In other words, when site users have more than one single sign-on, they don’t have single sign-on at all. With th